NOX4 promotes mucosal barrier injury in inflammatory bowel disease by mediating macrophages M1 polarization through ROS
- 1 March 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 104, 108361
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82000495)
This publication has 15 references indexed in Scilit:
- CBirTox is a selective antigen-specific agonist of the Treg-IgA-microbiota homeostatic pathwayPLOS ONE, 2017
- Antidepressants in Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2017
- Fecal biomarkers in inflammatory bowel diseaseJournal of Gastroenterology and Hepatology, 2017
- Pre-diagnostic genotyping identifies T1D subjects with impaired Treg IL-2 signaling and an elevated proportion of FOXP3+IL-17+ cellsGenes & Immunity, 2017
- IL-4 and IL13 promote liver fibrosis signaling through M2 macrophages, but not Th2 T cells or hepatocytesJournal of Hepatology, 2017
- IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivoJournal of Neuroinflammation, 2016
- Oridonin's therapeutic effect: Suppressing Th1/Th17 simultaneously in a mouse model of Crohn's diseaseJournal of Gastroenterology and Hepatology, 2015
- Pediatric inflammatory bowel disease: Increasing incidence, decreasing surgery rate, and compromised nutritional status: A prospective population-based cohort study 2007–2009Inflammatory Bowel Diseases, 2011
- Synergistic effect of TGF‐β superfamily members on the induction of Foxp3+ TregEuropean Journal of Immunology, 2009
- Critical role of IL‐2 and TGF‐β in generation, function and stabilization of Foxp3+CD4+ TregEuropean Journal of Immunology, 2008